Company: NDRA
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110887
Chunk: 120

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 120
---
 arrangement.

**Certain information has been omitted from the exhibit pursuant
to Item 601(b)(10) of Regulation S-K.

30

SIGNATURES

Pursuant to the requirements of Section 13 or
15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

    ENDRA LIFE SCIENCES INC.

    Date: November 14, 2025
    By: 
    /s/ Alexander Tokman

    Alexander Tokman

    Chief Executive Officer and Chairman

    (Principal Executive Officer)

    ENDRA LIFE SCIENCES INC.

    Date: November 14, 2025
    By:
    /s/ Richard Jacroux

    Richard Jacroux

    Chief Financial Officer

    (Principal Financial and Accounting Officer)

31

0001681682
false
Q3
--12-31

    0001681682

    2025-01-01
    2025-09-30

    0001681682

    2025-11-14

    0001681682

    2025-09-30

    0001681682

    2024-12-31

    0001681682
    
      us-gaap:SeriesAPreferredStockMember

    2025-09-30

    0001681682
    
      us-gaap:SeriesAPreferredStockMember

    2024-12-31

    0001681682
    
      us-gaap:SeriesBPreferredStockMember

    2025-09-30

    0001681682
    
      us-gaap:SeriesBPreferredStockMember

    2024-12-31

    0001681682
    
      us-gaap:SeriesCPreferredStockMember

    2025-09-30

    0001681682
    
      us-gaap:SeriesCPreferredStockMember

    2024-12-31

    0001681682

    2025-07-01
    2025-09-30

    0001681682

    2024-07-01
    2024-09-30

    0001681682

    2024-01-01
    2024-09